Michael King

Stock Analyst at EF Hutton

(0.79)
# 3,984
Out of 5,033 analysts
116
Total ratings
34.43%
Success rate
-15.72%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Michael King

Apollomics
Apr 1, 2024
Maintains: Buy
Price Target: $1,100$650
Current: $30.10
Upside: +2,059.47%
Sonnet BioTherapeutics Holdings
Aug 23, 2023
Assumes: Buy
Price Target: $1,179
Current: $4.01
Upside: +29,306.48%
Lantern Pharma
Aug 10, 2023
Reiterates: Buy
Price Target: $11
Current: $4.12
Upside: +167.31%
Biomea Fusion
Jun 26, 2023
Reiterates: Buy
Price Target: $32
Current: $1.60
Upside: +1,900.00%
Jasper Therapeutics
Jun 12, 2023
Reiterates: Buy
Price Target: $69
Current: $2.51
Upside: +2,629.08%
Coeptis Therapeutics Holdings
May 25, 2023
Assumes: Buy
Price Target: $200
Current: $14.98
Upside: +1,235.11%
Werewolf Therapeutics
May 25, 2023
Assumes: Buy
Price Target: $8.3
Current: $1.62
Upside: +412.35%
Regeneron Pharmaceuticals
May 1, 2023
Reiterates: Buy
Price Target: $862
Current: $576.77
Upside: +49.45%
Exelixis
Apr 28, 2023
Reiterates: Buy
Price Target: $24
Current: $34.54
Upside: -30.52%
Agenus
Mar 28, 2023
Reiterates: Buy
Price Target: $166
Current: $4.42
Upside: +3,655.66%
Reiterates: Buy
Price Target: $42
Current: $15.07
Upside: +178.70%
Reiterates: Buy
Price Target: $304
Current: $491.22
Upside: -38.11%
Maintains: Buy
Price Target: $123$116
Current: $27.98
Upside: +314.58%
Initiates: Buy
Price Target: $10
Current: $4.05
Upside: +154.32%
Initiates: Buy
Price Target: $24
Current: $27.92
Upside: -14.04%
Maintains: Buy
Price Target: $15,000$12,000
Current: $4.05
Upside: +296,196.30%
Maintains: Buy
Price Target: $43$46
Current: $35.27
Upside: +30.42%
Maintains: Buy
Price Target: $98$96
Current: $42.65
Upside: +125.09%
Initiates: Buy
Price Target: $36
Current: $0.75
Upside: +4,676.44%
Maintains: Buy
Price Target: $25$31
Current: $16.22
Upside: +91.12%
Maintains: Market Outperform
Price Target: $33$36
Current: $849.46
Upside: -95.76%